Dimensional Fund Advisors’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.21M Buy
882,101
+346,670
+65% +$1.26M ﹤0.01% 2633
2025
Q1
$1.03M Buy
535,431
+409,751
+326% +$786K ﹤0.01% 2878
2024
Q4
$239K Buy
+125,680
New +$239K ﹤0.01% 3139
2022
Q4
Sell
-627,549
Closed -$199K 3492
2022
Q3
$199K Sell
627,549
-155,126
-20% -$49.2K ﹤0.01% 3237
2022
Q2
$276K Sell
782,675
-1,884,186
-71% -$664K ﹤0.01% 3195
2022
Q1
$1.92M Buy
2,666,861
+73,020
+3% +$52.4K ﹤0.01% 2845
2021
Q4
$5.86M Buy
2,593,841
+498,078
+24% +$1.13M ﹤0.01% 2514
2021
Q3
$6.04M Sell
2,095,763
-1,309,358
-38% -$3.77M ﹤0.01% 2525
2021
Q2
$12.9M Buy
3,405,121
+972,862
+40% +$3.69M ﹤0.01% 2243
2021
Q1
$8.23M Buy
2,432,259
+684,955
+39% +$2.32M ﹤0.01% 2406
2020
Q4
$4.89M Sell
1,747,304
-10,432
-0.6% -$29.2K ﹤0.01% 2536
2020
Q3
$4.41M Sell
1,757,736
-141,985
-7% -$356K ﹤0.01% 2483
2020
Q2
$25.8M Buy
1,899,721
+55,298
+3% +$751K 0.01% 1721
2020
Q1
$14M Buy
1,844,423
+286,869
+18% +$2.17M 0.01% 1944
2019
Q4
$9.84M Buy
1,557,554
+301,930
+24% +$1.91M ﹤0.01% 2356
2019
Q3
$4.92M Buy
1,255,624
+203,888
+19% +$799K ﹤0.01% 2604
2019
Q2
$5.09M Buy
1,051,736
+162,755
+18% +$788K ﹤0.01% 2627
2019
Q1
$7.28M Sell
888,981
-53,618
-6% -$439K ﹤0.01% 2518
2018
Q4
$5.21M Buy
942,599
+488,972
+108% +$2.7M ﹤0.01% 2597
2018
Q3
$4.01M Buy
+453,627
New +$4.01M ﹤0.01% 2745
2017
Q4
Sell
-35,572
Closed -$700K 3324
2017
Q3
$700K Hold
35,572
﹤0.01% 3058
2017
Q2
$511K Hold
35,572
﹤0.01% 3086
2017
Q1
$327K Sell
35,572
-3,391
-9% -$31.2K ﹤0.01% 3153
2016
Q4
$406K Buy
38,963
+1,464
+4% +$15.3K ﹤0.01% 3121
2016
Q3
$339K Buy
37,499
+12,527
+50% +$113K ﹤0.01% 3122
2016
Q2
$187K Sell
24,972
-93
-0.4% -$696 ﹤0.01% 3187
2016
Q1
$226K Buy
25,065
+4,300
+21% +$38.8K ﹤0.01% 3166
2015
Q4
$268K Buy
+20,765
New +$268K ﹤0.01% 3180